NoSpoonFeeding
Well-Known Member
- Joined
- Sep 23, 2021
- Messages
- 2,339
- Reaction score
- 11,705
I was able to view part of Jelani's report and under ELISA it shows Benzodiazepines as 400 ng/g.
This article is a bit long but very interesting. I have no idea if this is relevant to JD's toxicology report, as I have not seen what Silver Spring is referring to.
Here are two different articles, it's a lot of reading.
In my opinion, it seems that due to not knowing the specific drug taken, it can't be said if the detected levels would be elevated OR diminished postmortem. The 2nd factor could be the postmortem redistribution of the drug (below) As one writer noted, it is more important to know why the drug was being taken, than what the level was postmortem, if not lethal.
Interpreting postmortem drug analysis and redistribution in determinin | PLMI
Interpreting postmortem drug analysis and redistribution in determining cause of death: a review Michael Kennedy Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, University of New South Wales, Sydney, NSW, Australia Abstract: Multiple interacting factors alter the...
www.dovepress.com
Bacterial invasion of the body commences almost immediately after death and metabolizes numerous sulfur-containing antipsychotics such as chlorpromazine, nitrobenzodiazepines such as clonazepam, and the benzisoxazole derivative risperidone at times, with only metabolites of the parent drugs being detected
Postmortem redistribution (PMR) is a term used to describe a complex array of variables that can lead to the redistribution of drugs after death, which in turn can result in quantitative concentration discrepancies.
Last edited: